The Role of PARP Inhibitors in Advanced Prostate Cancer
AUAUniversity29 Huhti 2023

The Role of PARP Inhibitors in Advanced Prostate Cancer

The Role of PARP Inhibitors in Advanced Prostate Cancer CME Available: https://auau.auanet.org/node/38241 Release Date: May, 2023 Expiration Date: May, 2024 Based on the documented need from the most recent AUA needs assessment in advanced prostate cancer, this symposium will address the role of PARP Inhibitor treatment, as well as evidence and outcomes of PARP Inhibitors as outlined in the newly amended Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline. At the conclusion of this activity, participants will be able to: 1. Review recommended criteria for genetic testing of prostate cancer patients and how to interpret these tests. 2. Explain the role of the enzyme poly ADP ribose polymerase (PARP) in carcinogenesis as well as the mechanism of PARP inhibition for cancer treatment. 3. Describe the role of PARP Inhibitor treatment alone and in combination with androgen receptor targeted therapies. 4. Review the evidence and outcomes on PARP Inhibitors as outlined in the newly amended Advanced Prostate Cancer: AUA/SUO Guideline. 5. Discuss clinical trial data assessing the efficacy of PARP inhibitors in advanced prostate cancer, including patient populations and clinical outcomes for each trial. ACKNOWLEDGEMENT This educational activity is supported by independent educational grants from: Pfizer, Inc.

Jaksot(422)

AUA2018 078IC - Management of Prostate Cancer: A Case Based Approach

AUA2018 078IC - Management of Prostate Cancer: A Case Based Approach

This course will provide a practical, evidence-based approach for the management of everyday problems in the management of prostate cancer, using a case-based approach with examples from real practice...

9 Elo 20182h 4min

AUA2018 019IC: Immunotherapy for the Urologist: Basic Principles, Adverse Effects & Drug Delivery

AUA2018 019IC: Immunotherapy for the Urologist: Basic Principles, Adverse Effects & Drug Delivery

The goal of the course is to provide both a basic and real-world application of immunotherapy for genitourinary oncology. The course is directed towards the urologist with an interest, but no prior ex...

1 Elo 20181h 55min

AUA2018 063IC - Prostate Cancer Update

AUA2018 063IC - Prostate Cancer Update

This course will offer a review of what faculty believe are the most important articles in the English-speaking literature on prostate cancer from May 2017 to April 2018. Focus will be placed on artic...

29 Heinä 20181h 59min

AUA2018 005IC - Chemotherapy and Immunotherapy Options for Genitourinary :A Primer for the APP

AUA2018 005IC - Chemotherapy and Immunotherapy Options for Genitourinary :A Primer for the APP

Review of current chemotherapy and immunotherapy regimens for genitourinary malignancies, including bladder, renal, and prostate cancers. Indications, outcomes, and toxicities will be discussed as wel...

25 Heinä 20181h 54min

AUA2018 058IC - Management of Common Dilemmas in Prostate Cancer Diagnosis, Staging and Treatment

AUA2018 058IC - Management of Common Dilemmas in Prostate Cancer Diagnosis, Staging and Treatment

We will discuss common PSA dilemmas: 1. Who should be screened? 2. What is the role of MRI in biopsy naive and men with prior negative biopsy? 3. What other markers can be used to determine whether bi...

11 Heinä 20182h 1min

Highlights in Renal Cell Carcinoma: Coordination of Care & the Patient's Journey (2018)

Highlights in Renal Cell Carcinoma: Coordination of Care & the Patient's Journey (2018)

The "Live from AUA2018" Highlights in Renal Cell Carcinoma series is comprised of three panel discussions which will focus on: Discussing the evolving landscape of adjuvant therapy for the treatment ...

5 Heinä 201831min

AUA2018 031IC: Contemporary Pharmacotherapy for OAB

AUA2018 031IC: Contemporary Pharmacotherapy for OAB

Much has been written and debated about drug treatment of overactive bladder (OAB) over the past two decades. Nevertheless, the field continues to evolve. OAB pharmacotherapy remains an area of active...

23 Kesä 20182h 12min

Focal Therapy Interview with John W. Davis, MD, FACS

Focal Therapy Interview with John W. Davis, MD, FACS

Dr. Nitti and Dr. Davis discus the use of focal therapy in the treatment of prostate cancer. @jdhdavis - This file has been updated

15 Kesä 201833min

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
rss-narsisti
voi-hyvin-meditaatiot-2
rss-vapaudu-voimaasi
rss-liian-kuuma-peruna
aamukahvilla
psykologia
dear-ladies
leveli
adhd-podi
kesken
rss-duodecim-lehti
avara-mieli
rahapuhetta
aloita-meditaatio
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-tietoinen-yhteys-podcast-2
filocast-filosofian-perusteet
rss-luonnollinen-synnytys-podcast